SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001493152-23-010431
Filing Date
2023-03-31
Accepted
2023-03-31 17:25:50
Documents
87
Period of Report
2022-12-31

Document Format Files

Seq Description Document Type Size
1 form10-k.htm   iXBRL 10-K 3138702
2 ex4-1.htm EX-4.1 31920
3 ex21-1.htm EX-21.1 6498
4 ex23-1.htm EX-23.1 3906
5 ex23-2.htm EX-23.2 4530
6 ex31-1.htm EX-31.1 12073
7 ex31-2.htm EX-31.2 12071
8 ex32.htm EX-32 9092
  Complete submission text file 0001493152-23-010431.txt   12724981

Data Files

Seq Description Document Type Size
9 INLINE XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT envb-20221231.xsd EX-101.SCH 76862
10 INLINE XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT envb-20221231_cal.xml EX-101.CAL 69050
11 INLINE XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT envb-20221231_def.xml EX-101.DEF 346868
12 INLINE XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT envb-20221231_lab.xml EX-101.LAB 646048
13 INLINE XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT envb-20221231_pre.xml EX-101.PRE 501936
81 EXTRACTED XBRL INSTANCE DOCUMENT form10-k_htm.xml XML 2458347
Mailing Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103
Business Address 4851 TAMIAMI TRAIL N, SUITE 200 NAPLES FL 34103 239-302-1707
Enveric Biosciences, Inc. (Filer) CIK: 0000890821 (see all company filings)

IRS No.: 954484725 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-38286 | Film No.: 23789314
SIC: 2834 Pharmaceutical Preparations